Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, December 22, 2016
The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to a new report by Grand View Research, Inc. The Pharmaceutical industry has been adaptive of the function of outsourcing certain clinical ...
read more
As part of its CareCentered Contracting program Prime Therapeutics recently entered into an outcomes-based contract with Boehringer Ingelheim for Jardiance.
read more
L2P Research, LLC, a preclinical CRO, announced the award of a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).
read more
Tuesday, November 28, 2023
Samsung Biologics, a prominent global contract development and manufacturing organization (CDMO), hosted its inaugural Suppliers ESG Day at its Songdo headquarters and online, marking a significant step toward sharing environmental, social, and ...
read more
LOTTE BIOLOGICS announced that it has signed a manufacturing agreement with an Asia-based biotech company for the production of a clinical-stage ADC candidate.
read more
ERT announced multiple options that enable trained healthcare professionals to advance respiratory clinical trials by collecting high-quality spirometry data during patient home visits.
read more
Monday, November 10, 2025
Avid Bioservices announced the appointment of Dave Stewart as Chief Technology and Transformation Officer, a newly created role designed to advance the company's next phase of growth and evolution.
read more
Thursday, January 22, 2015
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Mitsubishi Gas Chemical Company, Inc. (MGC), today jointly announced that they ...
read more
Janssen has entered into a worldwide exclusive license and collaboration agreement with Protagonist to develop, manufacture, and commercialize PTG-200.
read more
Sandra Lueken has assumed the role of Vice President, Head of Quality & Regulatory Affairs
read more
Wednesday, December 19, 2012
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it has completed its acquisition of Banner Pharmacaps ("Banner"), a specialty pharmaceutical business ...
read more
Perrigo Company has announced that Mr. Sharon Kochan, Perrigo's Executive Vice President and General Manager, International, will have expanded responsibilities that will now include providing leadership and strategic direction to the Company's ...
read more
Celerion announced the launch of on-site services for rapid sterility testing (validated alternative method to USP <71>) and dose formulation analysis.
read more
Wednesday, April 24, 2019
Arrowhead has begun dosing in a new triple combination cohort that includes JNJ-3989 and additional undisclosed agents selected by Janssen in its ongoing Phase 1/2 study in patients with chronic HBV.
read more
Monday, February 29, 2016
Valeant Pharmaceuticals has announced that J. Michael Pearson has returned as Valeant's chief executive officer following his recovery from severe pneumonia and other complications, effective immediately.
read more